Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

Shanghai BDgene Co., Ltd. · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
na
viral keratitis, blindness eye, herpes simplex virus infection, cornea, herpes simplex virus type 1 (hsv-1), crispr/cas9 mrna, instantaneous gene editing, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831794
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.